Markets.com Logo
markets.com

TARSF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

TARSF.US represents Tarsus Pharmaceuticals Inc. on the over-the-counter (OTC) market in the United States. Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address unmet needs in ophthalmic conditions. Their lead product, XDEMVY (lotilaner ophthalmic solution) 0.25%, is approved by the FDA for the treatment of Demodex blepharitis, a common eyelid margin disease caused by Demodex mites. As an OTC stock, TARSF.US may be subject to less stringent listing requirements and potentially greater price volatility compared to stocks listed on major exchanges like the NYSE or NASDAQ.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Tarpon Therapeutics, Inc (TARSF.US) stock price is influenced by various factors. Company Performance: Positive clinical trial results, FDA approvals, successful product launches, and strong earnings reports can drive the stock price higher. Conversely, negative trial data, regulatory setbacks, or poor financial performance can lead to price declines. Market Sentiment: Overall investor confidence and risk appetite significantly impact the stock. A bullish market often lifts most stocks, while a bearish market can drag them down, regardless of company specifics. Industry Trends: Developments in the biotechnology and pharmaceutical sectors, such as new drug discoveries, emerging technologies, or changes in healthcare regulations, can influence investor perception of Tarpon Therapeutics and its peers. Competition: The competitive landscape, including the emergence of new therapies or competitor actions, can affect Tarpon Therapeutics' market share and profitability, thus influencing its stock price. Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can affect investor sentiment and investment decisions, impacting stock valuations across the board. Regulatory Environment: Changes in regulations regarding drug development, pricing, and approval processes can significantly affect the pharmaceutical industry and, consequently, Tarpon Therapeutics' stock price. Financial Health: The company's cash position, debt levels, and ability to fund research and development activities are crucial factors affecting investor confidence. News and Events: Company-specific news, such as partnerships, acquisitions, or management changes, can trigger short-term price fluctuations.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com